Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 4/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
Hangzhou Greenda Electronic Materials Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥22.76 |
52 Week High | CN¥31.37 |
52 Week Low | CN¥16.72 |
Beta | -0.0099 |
11 Month Change | 7.92% |
3 Month Change | 20.74% |
1 Year Change | -24.39% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -24.28% |
Recent News & Updates
Recent updates
Shareholder Returns
603931 | CN Chemicals | CN Market | |
---|---|---|---|
7D | 7.8% | -1.8% | -1.2% |
1Y | -24.4% | -7.8% | 3.1% |
Return vs Industry: 603931 underperformed the CN Chemicals industry which returned -7.8% over the past year.
Return vs Market: 603931 underperformed the CN Market which returned 3.1% over the past year.
Price Volatility
603931 volatility | |
---|---|
603931 Average Weekly Movement | 7.8% |
Chemicals Industry Average Movement | 7.3% |
Market Average Movement | 7.9% |
10% most volatile stocks in CN Market | 12.0% |
10% least volatile stocks in CN Market | 5.4% |
Stable Share Price: 603931 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603931's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2001 | 261 | Weihua Fang | www.greendachem.com/en |
Hangzhou Greenda Electronic Materials Co., Ltd. engages in the research and development, production, and servicing of high-purity electronic chemicals in China and internationally. It offers wet electronic chemicals; hydrochloric, nitric, sulphuric, hydrofluoric, acetic, fluosilicic, and phosphoric acid; tetramethylammonium hydroxide; isopropanol; ?-butyrolactone; n-methyl pyrrolidone; KOH developer; and Cu etchant, as well as electronic grade buffer oxidation etchant.
Hangzhou Greenda Electronic Materials Co., Ltd. Fundamentals Summary
603931 fundamental statistics | |
---|---|
Market cap | CN¥4.54b |
Earnings (TTM) | CN¥163.61m |
Revenue (TTM) | CN¥687.97m |
27.8x
P/E Ratio6.6x
P/S RatioIs 603931 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
603931 income statement (TTM) | |
---|---|
Revenue | CN¥687.97m |
Cost of Revenue | CN¥435.72m |
Gross Profit | CN¥252.25m |
Other Expenses | CN¥88.64m |
Earnings | CN¥163.61m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.82 |
Gross Margin | 36.67% |
Net Profit Margin | 23.78% |
Debt/Equity Ratio | 0% |
How did 603931 perform over the long term?
See historical performance and comparison